A Comprehensive Ensemble Learning Approach for Identifying Non-Small Cell Lung Cancer Through T-Cell Receptor Sequencing - Top-Institutions - MDSpire

A Comprehensive Ensemble Learning Approach for Identifying Non-Small Cell Lung Cancer Through T-Cell Receptor Sequencing

  • By

  • Wenjian Wang

  • Xueting Hu

  • Yi Luan

  • Wenzeng Chen

  • Qinxuan Zhu

  • Guiping Tian

  • Qihao Zheng

  • Jing Meng

  • Chuan Wang

  • Minghui Wang

  • February 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Immunology
    • Genomics

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Immunology
    • Computational Biology

  • #3

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Immunology
    • Bioinformatics

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Immunology
    • Molecular Biology

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology
    • Immunology
    • Genomics

Original Source(s)

A Comprehensive Ensemble Learning Approach for Identifying Non-Small Cell Lung Cancer Through T-Cell Receptor Sequencing

  • by Wenjian Wang, Xueting Hu, Yi Luan, Wenzeng Chen, Qinxuan Zhu, Guiping Tian, Qihao Zheng, Jing Meng, Chuan Wang, Minghui Wang

  • February 11, 2026

Related Content

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Potential targets for boron transport in boron neutron capture therapy